Labs / ADME, DMPK & toxicology
Nona Biosciences
Cambridge, MA, United States · nonabio.com
Nona Biosciences is a global biotechnology company that provides integrated antibody and siRNA discovery through IND filing. It serves drug discovery and development partners with technologies and services spanning target validation, discovery, screening, engineering, toxicology, and IND-enabling CMC.
They take quote requests by email.
What they offer
Fully Human Antibody Discovery
Supports discovery of fully human antibodies from target validation through lead generation.
siRNA Discovery
Provides discovery workflows for siRNA therapeutics.
Antibody Screening Capabilities
Offers screening strategies including single B cell, CAR-based, display, and hybridoma screening.
Beacon Single B Cell Screening
Uses Beacon-based single B cell screening to identify antibody binders and candidates.
CAR-based Functional Screening
Performs functional screening using CAR-based approaches.
Display Screening
Screens antibody candidates using display-based methods.
Hybridoma Screening
Screens hybridoma-derived antibodies for candidate selection.
Antibody Engineering Capability
Provides antibody engineering to optimize lead molecules.
Bispecific/Multispecific Antibody Engineering
Designs and engineers bispecific and multispecific antibody formats.
Bispecific Antibody Developability Assessment
Assesses bispecific antibodies for developability properties.
ADC Engineering & Conjugation
Supports antibody-drug conjugate engineering and conjugation work.
Toxicology and Safety Assessment
Provides toxicology and safety assessment services.
IND-enabling CMC
Supports IND-enabling chemistry, manufacturing, and controls activities.
Targeted Cargo Delivery Systems
Develops targeted delivery systems for cargo modalities.
mRNA-LNP Delivery
Develops mRNA delivery using lipid nanoparticles.
Blood Brain Barrier Delivery
Works on delivery systems for crossing the blood-brain barrier.
In Vivo CAR Delivery
Develops in vivo CAR delivery approaches.
Oligonucleotide Delivery
Develops delivery systems for oligonucleotides.
Integrated Idea – IND Program
Provides an integrated path from ideation to IND filing.
What they work on
- Modalities
- Antibody, Bispecific, ADC, Oligonucleotide, mRNA, Cell therapy, LNP / formulation
- Species and models
- Harbour Mice® HCAb, Harbour Mice® H2L2, mice, Beacon, hybridoma
- Assays and studies
- single B cell screening, B cell sorting, functional screening, display screening, hybridoma screening, developability assessment, affinity prioritization
- Instruments and platforms
- Beacon
- Scale and capacity
- 140+ partners, 380+ projects, 20+ IND/Clinical Stage
- Type
- CRDMO
- Serves
- global
- Address
- 2026 Nona Biosciences Appoints Dr. Peng Wang as Chief Operating Officer to Advance Platform Capabilitie
Similar labs. Aurigene Pharmaceutical Services, Transcenta Holding, Sparx BIO, Evotec
Found in a contract services directory. Listing built from nonabio.com. Work here? Claim this listing.